Figure 1From: Activity of hypertonic solution with Silver and Potassium Sucrose Octasulfate on nasal symptoms in obstructive rhinopathy with and without rhinosinusitis SNOT-22, VAS Primary Simptoms and VAS Primary + Secondary Simptoms variation at T10 and T20. On the overall treatment period (T0-T20), MD improved VAS total score for primary, primary + secondary symptoms, and SNOT-22 mean score (p < 0.05 vs T0).Back to article page